Ice Gel Manufacturing
Delhi
About Company
Description
Gel formulation for wound healing
Contact Information
Primary Phone
Primary Email
Website
Registered Address
State
Delhi
Country
India
Business Information
Business Types
Manufacturer
Manufacturing Units
1
Legal & Compliance
Certifications & Approvals
WHO-GMP
Not Certified
ISO
Not Certified
GMP
Not Certified
FSSAI
Not Certified
USFDA
Not Approved
EU-GMP
Not Certified
UK-MHRA
Not Approved
WHO Prequalified
No
PCD/Franchise Information
PCD Franchisor
No
Products
Total products: 6
| Product Name | Dosage Form | Composition | Therapeutic Category |
|---|---|---|---|
| COVID Sars-Coronavirus MERS RSV MPOX / SMALLPOX VZV "SHINGLES DERMAL TOPICAL CREAM | Cream | - | - |
| COVID Sars-Coronavirus MERS RSV MPOX / SMALLPOX VZV "SHINGLES DERMAL TOPICAL CREAM | Cream | - | - |
| NanoViricides advances toward fully funded Phase II MPox trial in DRC Feb. 19, 2026 Anil Diwan on Building Revolutionary Antiviral Therapies Jan 29, 2026 NanoViricides receives approval to start Phase | - | - | Antivirals |
| NanoViricides advances toward fully funded Phase II MPox trial in DRC Feb. 19, 2026 Anil Diwan on Building Revolutionary Antiviral Therapies Jan 29, 2026 NanoViricides receives approval to start Phase | - | - | Antivirals |
| NanoViricides Product Pipeline COVID Sars-Coronavirus MERS RSV MPOX / SMALLPOX VZV "SHINGLES DERMAL TOPICAL CREAM HSV -1 "GENITAL LESIONS" HSV-2 "COLD SORES" HIVCIDE Potentially "Functional Cure" EBOL | Cream | - | - |
| NanoViricides Product Pipeline COVID Sars-Coronavirus MERS RSV MPOX / SMALLPOX VZV "SHINGLES DERMAL TOPICAL CREAM HSV -1 "GENITAL LESIONS" HSV-2 "COLD SORES" HIVCIDE Potentially "Functional Cure" EBOL | Cream | - | - |
Social Media
Company Status
Status
Active
Verification
Verified
Statistics
Profile Views
65
Total Inquiries
0